1. Advances in the Pharmacotherapy of Migraine

   • Peter J. Goadsby

   Section 1: Migraine 07 October 2012 Pages: 361 - 374

2. Drugs in Development for Migraine

   • Katharine J. Palmer
   • Joanne Dalton

   Section 1: Migraine 07 October 2012 Pages: 375 - 379

3. Botulinum Toxin A (Allergan)

   Section 1: Migraine 07 October 2012 Pages: 381 - 382

4. Dapitant

   Section 1: Migraine 07 October 2012 Pages: 383 - 384

5. Gabapentin

   Section 1: Migraine 07 October 2012 Pages: 385 - 389

6. IS 159

   Section 1: Migraine 07 October 2012 Pages: 390 - 391

7. S-fluoxetine

   Section 1: Migraine 07 October 2012 Pages: 392 - 392

8. Vigabatrin

   Section 1: Migraine 07 October 2012 Pages: 393 - 396

9. Zatosetron

   Section 1: Migraine 07 October 2012 Pages: 397 - 399

10. Men’s Health

    • Katharine J. Palmer
    • Lynda Wiseman
    • Raewyn Poole

    Section 2: Men’s Health 07 October 2012 Pages: 401 - 411

11. Alprostadil (NexMed)

    Section 2: Men’s Health 07 October 2012 Pages: 413 - 414

12. Apomorphine (TAP Holdings)

    Section 2: Men’s Health 07 October 2012 Pages: 415 - 416

13. Bunazosin

    Section 2: Men’s Health 07 October 2012 Pages: 417 - 419

14. Deslorelin

    Section 2: Men’s Health 07 October 2012 Pages: 420 - 422

15. Follitropin-α

    Section 2: Men’s Health 07 October 2012 Pages: 423 - 424

16. Leuprorelin Implant (ALZA)

    Section 2: Men’s Health 07 October 2012 Pages: 425 - 426

17. Liarozole

    Section 2: Men’s Health 07 October 2012 Pages: 427 - 430

18. Suramin Sodium

    Section 2: Men’s Health 07 October 2012 Pages: 431 - 435

19. Vasoactive Intestinal Peptide/Phentolamine

    Section 2: Men’s Health 07 October 2012 Pages: 436 - 438